Clinical Trials
3 trialsNCT04038502 2025-08-20
COBRA
VA Office of Research and Development
Phase 2 Recruiting
NCT05485766 2025-03-20
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
Okayama University
Phase 2 Recruiting
NCT02418624 2019-01-16
REVIVAL
The Netherlands Cancer Institute
Phase 1 Completed